The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
Recruiting now · Not applicable
Conditions studied: Organ Failure, Multiple, Indigestion, Delayed Gastric Emptying, Respiratory Failure, Morality
In brief
Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU). The goal of this clinical trial is to learn if traditional Chinese medicine(TCM) is effective for prevention and treatment of organ failure in ICU patients. Patients in this group will receive intervention for 2 weeks. A multi-center non-randomized real word data study, will include 3 groups: intervention group (TCM)(n=70), control group and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023). Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.
Key facts
- Study ID
- NCT06452966
- Run by
- China Medical University Hospital
- People needed
- 350
- Starts
- 2024-05-07
- Expected to finish
- 2027-05-30
- Last updated by the study team
- 2024-06-11
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 20 and above
- Surgical ICU patients
- The use of Chinese medicine must be approved by the attending physician in the surgical intensive care unit
You may not qualify if…
- Patients' family members refuse TCM intervention
Where it is running
- China Medical University Hospital — Taichung, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.